Logo image of NEWU.CA

NEWTOPIA INC (NEWU.CA) Stock Fundamental Analysis

TSX-V:NEWU - TSX Venture Exchange - CA6532261006 - Common Stock - Currency: CAD

0.005  0 (0%)

Fundamental Rating

1

NEWU gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 17 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of NEWU have multiple concerns. NEWU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NEWU had negative earnings in the past year.
In the past year NEWU has reported a negative cash flow from operations.
In the past 5 years NEWU always reported negative net income.
NEWU had a negative operating cash flow in each of the past 5 years.
NEWU.CA Yearly Net Income VS EBIT VS OCF VS FCFNEWU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

NEWU has a worse Return On Assets (-1091.37%) than 88.24% of its industry peers.
Industry RankSector Rank
ROA -1091.37%
ROE N/A
ROIC N/A
ROA(3y)-183.8%
ROA(5y)-166.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NEWU.CA Yearly ROA, ROE, ROICNEWU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 -400

1.3 Margins

NEWU has a Gross Margin of 49.88%. This is amongst the best in the industry. NEWU outperforms 88.24% of its industry peers.
NEWU's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NEWU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y13.03%
NEWU.CA Yearly Profit, Operating, Gross MarginsNEWU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -200 -400

More info and screens

0

2. Health

2.1 Basic Checks

NEWU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NEWU has more shares outstanding
Compared to 5 years ago, NEWU has more shares outstanding
The debt/assets ratio for NEWU is higher compared to a year ago.
NEWU.CA Yearly Shares OutstandingNEWU.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
NEWU.CA Yearly Total Debt VS Total AssetsNEWU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

NEWU has an Altman-Z score of -158.48. This is a bad value and indicates that NEWU is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NEWU (-158.48) is worse than 88.24% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -158.48
ROIC/WACCN/A
WACC6.79%
NEWU.CA Yearly LT Debt VS Equity VS FCFNEWU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M

2.3 Liquidity

A Current Ratio of 0.05 indicates that NEWU may have some problems paying its short term obligations.
With a Current ratio value of 0.05, NEWU is not doing good in the industry: 82.35% of the companies in the same industry are doing better.
NEWU has a Quick Ratio of 0.05. This is a bad value and indicates that NEWU is not financially healthy enough and could expect problems in meeting its short term obligations.
NEWU has a Quick ratio of 0.04. This is amonst the worse of the industry: NEWU underperforms 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.04
NEWU.CA Yearly Current Assets VS Current LiabilitesNEWU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

NEWU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.51%.
NEWU shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.40%.
Measured over the past years, NEWU shows a very strong growth in Revenue. The Revenue has been growing by 26.06% on average per year.
EPS 1Y (TTM)-19.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90%
Revenue 1Y (TTM)-36.4%
Revenue growth 3Y-5.01%
Revenue growth 5Y26.06%
Sales Q2Q%-59.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year29.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEWU.CA Yearly Revenue VS EstimatesNEWU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NEWU.CA Yearly EPS VS EstimatesNEWU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NEWU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NEWU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEWU.CA Price Earnings VS Forward Price EarningsNEWU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NEWU.CA Per share dataNEWU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NEWU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEWTOPIA INC

TSX-V:NEWU (4/23/2025, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-22 2024-11-22
Earnings (Next)05-21 2025-05-21/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners22.49%
Ins Owner ChangeN/A
Market Cap866.35K
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.04
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1091.37%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.88%
FCFM N/A
ROA(3y)-183.8%
ROA(5y)-166.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y13.03%
F-Score3
Asset Turnover10.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.04
Altman-Z -158.48
F-Score3
WACC6.79%
ROIC/WACCN/A
Cap/Depr(3y)0.92%
Cap/Depr(5y)21.1%
Cap/Sales(3y)0.03%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90%
EPS Next Y75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.4%
Revenue growth 3Y-5.01%
Revenue growth 5Y26.06%
Sales Q2Q%-59.5%
Revenue Next Year29.37%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year111.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y75.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.7%
OCF growth 3YN/A
OCF growth 5YN/A